Spearheading Cannabinoid And Psychedelic Medicine In The U.S. And Australia: Meet Incannex Healthcare
20m | Jan 25, 2024Today's Benzinga Interviews is all about the #Cannabinoid And #Psychedelic industry.
Guest:
Joel Latham is the CEO and Managing Director of Incannex Healthcare (NASDAQ: IXHL). He is responsible for the Company’s commercial operations, strategic decision- making, and oversight of all clinical development assets. Joel has over 15 years commercial management and executive experience, working for a range multi-national publicly traded companies.
Hosted by: Lara Goldstein
The Benzinga Interviews
Loading...